FDA Inspection 1315610 — Northwest Center for Infertility and Reproductive Endocrinology dba IVF Florida
The FDA completed an inspection of Northwest Center for Infertility and Reproductive Endocrinology dba IVF Florida on April 14, 2026 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jacksonville, FL (United States)